| Category |
Oncology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Treatment of gastric cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Michele Orditura, Gennaro Galizia, Vincenzo Sforza, Valentina Gambardella, Alessio Fabozzi, Maria Maddalena Laterza, Francesca Andreozzi, Jole Ventriglia, Beatrice Savastano, Andrea Mabilia, Eva Lieto, Fortunato Ciardiello and Ferdinando De Vita |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Michele Orditura, MD, PhD, Division of Medical Oncology, Dipartimento di Medicina, Clinica e Sperimentale ‘F. Magrassi-A. Lanzara’, Seconda Università degli Studi di Napoli, c/o II Policlinico, via S. Pansini 5, 80131 Naples, Italy. michele.orditura@unina2.it |
| Key Words |
Gastric cancer; Surgery; Radiotherapy; Adjuvant chemotherapy; Palliative chemotherapy; Chemoradiation |
| Core Tip |
Surgery remains the only curative therapy of localized gastric cancer, while perioperative and adjuvant chemotherapy, as well as chemoradiation, can improve outcome. Cisplatin and fluoropyrimidine-based chemotherapy, with addition of trastuzumab in human epidermal growth factor receptor 2 positive patients, is the widely used treatment in stage Ⅳ patients. Second-line chemotherapy after progression in patients with good performance status represents a good option. |
| Publish Date |
2014-03-12 11:24 |
| Citation |
Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J, Savastano B, Mabilia A, Lieto E, Ciardiello F, De Vita F. Treatment of gastric cancer. World J Gastroenterol 2014; 20(7): 1635-1649 |
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i7/1635.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i7.1635 |
